Great Point Partners LLC
- SEC CIK
- 0001281446
- Latest filing
- Aug 14, 2026
Holdings in Q1 2021
Holdings as of Mar 31, 2021, filed May 17, 2021. Long positions only.
- Positions
- 28
- No 13F data for Q4 2020
- Portfolio value
- $483.9M
- No 13F data for Q4 2020
Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MGNXMacrogenics Inc | COM | 1,350,000 | $43.0M | 8.9% | – | – | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 760,000 | $33.7M | 7.0% | – | – | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 930,000 | $29.4M | 6.1% | – | – | History |
| SAGESage Therapeutics, Inc. | COM | 382,085 | $28.6M | 5.9% | – | – | History |
| XENTIntersect ENT, Inc. | COM | 1,332,773 | $27.8M | 5.8% | – | – | History |
| EXELExelixis, Inc. | COM | 1,201,100 | $27.1M | 5.6% | – | – | History |
| UTHRUnited Therapeutics Corp | COM | 156,406 | $26.2M | 5.4% | – | – | History |
| ARNAArena Pharmaceuticals Inc | COM NEW | 375,870 | $26.1M | 5.4% | – | – | History |
| PODDInsulet Corp | Stock | 89,600 | $23.4M | 4.8% | – | – | History |
| MRTXMirati Therapeutics, Inc. | COM | 135,000 | $23.1M | 4.8% | – | – | History |
| BIIBBiogen Inc. | COM | 75,000 | $21.0M | 4.3% | – | – | History |
| COLLCollegium Pharmaceutical, Inc | COM | 861,410 | $20.4M | 4.2% | – | – | History |
| CNSTConstellation Pharmaceuticals Inc | COM | 872,415 | $20.4M | 4.2% | – | – | History |
| KDMNKadmon Holdings, Inc. | COM | 4,755,000 | $18.5M | 3.8% | – | – | History |
| OCULOcular Therapeutix, Inc | COM | 1,007,012 | $16.5M | 3.4% | – | – | History |
| TVTXTravere Therapeutics, Inc. | COM | 593,712 | $14.8M | 3.1% | – | – | History |
| LNTHLantheus Holdings, Inc. | Stock | 649,516 | $13.9M | 2.9% | – | – | History |
| PBYIPuma Biotechnology, Inc. | COM | 1,300,000 | $12.6M | 2.6% | – | – | History |
| NVRONevro Corp | COM | 80,000 | $11.2M | 2.3% | – | – | History |
| IFRXInflaRx N.V. | COM | 2,200,000 | $8.58M | 1.8% | – | – | History |
| ACADAcadia Pharmaceuticals Inc | COM | 311,217 | $8.03M | 1.7% | – | – | History |
| LUNGPulmonx Corp | COM | 114,345 | $5.23M | 1.1% | – | – | History |
| RDHLRedHill Biopharma Ltd. | SPONSORED ADS | 705,305 | $5.16M | 1.1% | – | – | History |
| RXDXPrometheus Biosciences, Inc. | COM | 250,000 | $4.57M | 0.9% | – | – | History |
| YMABY-mAbs Therapeutics, Inc. | COM | 150,000 | $4.54M | 0.9% | – | – | History |
| GERNGeron Corp | COM | 2,610,000 | $4.12M | 0.9% | – | – | History |
| SYRESpyre Therapeutics, Inc. | COM | 502,900 | $3.98M | 0.8% | – | – | History |
| TCDATricida, Inc. | COM | 349,600 | $1.85M | 0.4% | – | – | History |